Christopher G. Willett
Publications by Year
Research Areas
Colorectal and Anal Carcinomas, Colorectal Cancer Surgical Treatments, Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer(2004)1,946 cited
- → Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology(2021)1,707 cited
- → Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,640 cited
- → Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology(2017)1,366 cited
- → Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781(2008)1,348 cited
- → Prognostic Factors in Colorectal Cancer(2000)1,227 cited
- → Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology